 Centogene N.V. CNTG, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced it will be offering COVID-19 testing for nursing homes in the state of Mecklenburg-Western Pomerania, Germany - the location of the Companys headquarters. By providing tests to nursing homes, we aim to protect the vulnerable nursing home population and diagnose them at the earliest possible point. 